Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59


Single-Cell Transcriptome Analysis of CD34+ Stem Cell-Derived Myeloid Cells Infected With Human Cytomegalovirus.

Galinato M, Shimoda K, Aguiar A, Hennig F, Boffelli D, McVoy MA, Hertel L.

Front Microbiol. 2019 Mar 21;10:577. doi: 10.3389/fmicb.2019.00577. eCollection 2019.


Inclusion of Antibodies to Cell Culture Media Preserves the Integrity of Genes Encoding RL13 and the Pentameric Complex Components During Fibroblast Passage of Human Cytomegalovirus.

Ourahmane A, Cui X, He L, Catron M, Dittmer DP, Al Qaffasaa A, Schleiss MR, Hertel L, McVoy MA.

Viruses. 2019 Mar 5;11(3). pii: E221. doi: 10.3390/v11030221.


Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response.

Cui X, Cao Z, Wang S, Lee RB, Wang X, Murata H, Adler SP, McVoy MA, Snapper CM.

Vaccine. 2018 Sep 5;36(37):5580-5590. doi: 10.1016/j.vaccine.2018.07.056. Epub 2018 Aug 3.


A Guinea pig cytomegalovirus resistant to the DNA maturation inhibitor BDCRB.

Ourahmane A, Sauer A, Nixon DE, Murphy C, Mondello M, Douglass Chiu E, Siegmund S, Wang JB, McVoy MA.

Antiviral Res. 2018 Jun;154:44-50. doi: 10.1016/j.antiviral.2018.04.006. Epub 2018 Apr 9.


WDR5 Facilitates Human Cytomegalovirus Replication by Promoting Capsid Nuclear Egress.

Yang B, Liu XJ, Yao Y, Jiang X, Wang XZ, Yang H, Sun JY, Miao Y, Wang W, Huang ZL, Wang Y, Tang Q, Rayner S, Britt WJ, McVoy MA, Luo MH, Zhao F.

J Virol. 2018 Apr 13;92(9). pii: e00207-18. doi: 10.1128/JVI.00207-18. Print 2018 May 1.


Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans.

Murray SE, Nesterenko PA, Vanarsdall AL, Munks MW, Smart SM, Veziroglu EM, Sagario LC, Lee R, Claas FHJ, Doxiadis IIN, McVoy MA, Adler SP, Hill AB.

J Exp Med. 2017 Jul 3;214(7):1889-1899. doi: 10.1084/jem.20161988. Epub 2017 May 31.


Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization.

Cui X, Adler SP, Schleiss MR, Arav-Boger R, Demmler Harrison GJ, McVoy MA.

Clin Vaccine Immunol. 2017 Jun 5;24(6). pii: e00024-17. doi: 10.1128/CVI.00024-17. Print 2017 Jun.


Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and Toledo.

Suárez NM, Lau B, Kemble GM, Lee R, Mocarski ES, Wilkinson GWG, Adler SP, McVoy MA, Davison AJ.

Virus Genes. 2017 Aug;53(4):650-655. doi: 10.1007/s11262-017-1452-0. Epub 2017 Apr 8.


Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.

Cui X, Freed DC, Wang D, Qiu P, Li F, Fu TM, Kauvar LM, McVoy MA.

J Virol. 2017 Jun 9;91(13). pii: e01650-16. doi: 10.1128/JVI.01650-16. Print 2017 Jul 1.


Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.

Ha S, Li F, Troutman MC, Freed DC, Tang A, Loughney JW, Wang D, Wang IM, Vlasak J, Nickle DC, Rustandi RR, Hamm M, DePhillips PA, Zhang N, McLellan JS, Zhu H, Adler SP, McVoy MA, An Z, Fu TM.

J Virol. 2017 Mar 13;91(7). pii: e02033-16. doi: 10.1128/JVI.02033-16. Print 2017 Apr 1.


A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.

Adler SP, Manganello AM, Lee R, McVoy MA, Nixon DE, Plotkin S, Mocarski E, Cox JH, Fast PE, Nesterenko PA, Murray SE, Hill AB, Kemble G.

J Infect Dis. 2016 Nov 1;214(9):1341-1348. Epub 2016 Aug 11.


Repair of a Mutation Disrupting the Guinea Pig Cytomegalovirus Pentameric Complex Acquired during Fibroblast Passage Restores Pathogenesis in Immune-Suppressed Guinea Pigs and in the Context of Congenital Infection.

McVoy MA, Wang JB, Dittmer DP, Bierle CJ, Swanson EC, Fernández-Alarcón C, Hernandez-Alvarado N, Zabeli JC, Schleiss MR.

J Virol. 2016 Aug 12;90(17):7715-27. doi: 10.1128/JVI.00320-16. Print 2016 Sep 1.


Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.

Bierle CJ, Anderholm KM, Wang JB, McVoy MA, Schleiss MR.

J Virol. 2016 Jul 11;90(15):6989-6998. doi: 10.1128/JVI.00139-16. Print 2016 Aug 1.


A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.

McVoy MA, Lee R, Saccoccio FM, Hartikka J, Smith LR, Mahajan R, Wang JB, Cui X, Adler SP.

Vaccine. 2015 Dec 16;33(51):7328-7336. doi: 10.1016/j.vaccine.2015.10.078. Epub 2015 Oct 24.


Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.

Schleiss MR, Bierle CJ, Swanson EC, McVoy MA, Wang JB, Al-Mahdi Z, Geballe AP.

J Virol. 2015 Oct;89(19):9727-38. doi: 10.1128/JVI.01419-15. Epub 2015 Jul 15.


Human Cytomegalovirus Infection Dysregulates the Localization and Stability of NICD1 and Jag1 in Neural Progenitor Cells.

Li XJ, Liu XJ, Yang B, Fu YR, Zhao F, Shen ZZ, Miao LF, Rayner S, Chavanas S, Zhu H, Britt WJ, Tang Q, McVoy MA, Luo MH.

J Virol. 2015 Jul;89(13):6792-804. doi: 10.1128/JVI.00351-15. Epub 2015 Apr 22.


A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.

Kauvar LM, Liu K, Park M, DeChene N, Stephenson R, Tenorio E, Ellsworth SL, Tabata T, Petitt M, Tsuge M, Fang-Hoover J, Adler SP, Cui X, McVoy MA, Pereira L.

Antimicrob Agents Chemother. 2015 Mar;59(3):1558-68. doi: 10.1128/AAC.04295-14. Epub 2014 Dec 22.


Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL.

Alam Z, Al-Mahdi Z, Zhu Y, McKee Z, Parris DS, Parikh HI, Kellogg GE, Kuchta A, McVoy MA.

Antiviral Res. 2015 Feb;114:86-95. doi: 10.1016/j.antiviral.2014.12.003. Epub 2014 Dec 10.


Complete genome sequence of cell culture-attenuated Guinea pig cytomegalovirus cloned as an infectious bacterial artificial chromosome.

Yang D, Alam Z, Cui X, Chen M, Sherrod CJ, McVoy MA, Schleiss MR, Dittmer DP.

Genome Announc. 2014 Oct 16;2(5). pii: e00928-14. doi: 10.1128/genomeA.00928-14.


Molecular and biological characterization of a new isolate of guinea pig cytomegalovirus.

Schleiss MR, McAllister S, Armién AG, Hernandez-Alvarado N, Fernández-Alarcón C, Zabeli JC, Ramaraj T, Crow JA, McVoy MA.

Viruses. 2014 Jan 27;6(2):448-75. doi: 10.3390/v6020448.


Cytomegalovirus vaccines.

McVoy MA.

Clin Infect Dis. 2013 Dec;57 Suppl 4:S196-9. doi: 10.1093/cid/cit587. Review.


Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.

Bhave S, Elford H, McVoy MA.

Antiviral Res. 2013 Oct;100(1):151-8. doi: 10.1016/j.antiviral.2013.07.016. Epub 2013 Aug 6.


Antibody inhibition of human cytomegalovirus spread in epithelial cell cultures.

Cui X, Lee R, Adler SP, McVoy MA.

J Virol Methods. 2013 Sep;192(1-2):44-50. doi: 10.1016/j.jviromet.2013.04.015. Epub 2013 May 10.


Complete genome sequence of pathogenic Guinea pig cytomegalovirus from salivary gland homogenates of infected animals.

Yang D, Tamburro K, Dittmer D, Cui X, McVoy MA, Hernandez-Alvarado N, Schleiss MR.

Genome Announc. 2013 Mar 14;1(2):e0005413. doi: 10.1128/genomeA.00054-13.


Changes in subcellular localization reveal interactions between human cytomegalovirus terminase subunits.

Wang JB, Zhu Y, McVoy MA, Parris DS.

Virol J. 2012 Dec 21;9:315. doi: 10.1186/1743-422X-9-315.


Bacterial artificial chromosome clones of viruses comprising the towne cytomegalovirus vaccine.

Cui X, Adler SP, Davison AJ, Smith L, Habib el-SE, McVoy MA.

J Biomed Biotechnol. 2012;2012:428498. doi: 10.1155/2012/428498. Epub 2011 Nov 30.


Structural modelling and mutagenesis of human cytomegalovirus alkaline nuclease UL98.

Kuchta AL, Parikh H, Zhu Y, Kellogg GE, Parris DS, McVoy MA.

J Gen Virol. 2012 Jan;93(Pt 1):130-8. doi: 10.1099/vir.0.034876-0. Epub 2011 Sep 7.


Neutralizing activity of saliva against cytomegalovirus.

Saccoccio FM, Gallagher MK, Adler SP, McVoy MA.

Clin Vaccine Immunol. 2011 Sep;18(9):1536-42. doi: 10.1128/CVI.05128-11. Epub 2011 Jul 27.


Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model.

Olejniczak MJ, Choi KY, McVoy MA, Cui X, Schleiss MR.

Virol J. 2011 Mar 3;8:89. doi: 10.1186/1743-422X-8-89.


Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells.

Saccoccio FM, Sauer AL, Cui X, Armstrong AE, Habib el-SE, Johnson DC, Ryckman BJ, Klingelhutz AJ, Adler SP, McVoy MA.

Vaccine. 2011 Mar 24;29(15):2705-11. doi: 10.1016/j.vaccine.2011.01.079. Epub 2011 Feb 22.


A human cytomegalovirus deleted of internal repeats replicates with near wild type efficiency but fails to undergo genome isomerization.

Sauer A, Wang JB, Hahn G, McVoy MA.

Virology. 2010 May 25;401(1):90-5. doi: 10.1016/j.virol.2010.02.016. Epub 2010 Mar 7.


The impact of genome length on replication and genome stability of the herpesvirus guinea pig cytomegalovirus.

Cui X, McGregor A, Schleiss MR, McVoy MA.

Virology. 2009 Mar 30;386(1):132-8. doi: 10.1016/j.virol.2008.12.030. Epub 2009 Jan 26.


Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome.

Schleiss MR, McGregor A, Choi KY, Date SV, Cui X, McVoy MA.

Virol J. 2008 Nov 12;5:139. doi: 10.1186/1743-422X-5-139.


Mutagenesis of the murine cytomegalovirus M56 terminase gene.

Wang JB, McVoy MA.

J Gen Virol. 2008 Nov;89(Pt 11):2864-8. doi: 10.1099/vir.0.2008/003137-0.


Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection.

Cui X, Meza BP, Adler SP, McVoy MA.

Vaccine. 2008 Oct 23;26(45):5760-6. doi: 10.1016/j.vaccine.2008.07.092. Epub 2008 Aug 19.


Cloning the complete guinea pig cytomegalovirus genome as an infectious bacterial artificial chromosome with excisable origin of replication.

Cui X, McGregor A, Schleiss MR, McVoy MA.

J Virol Methods. 2008 May;149(2):231-9. doi: 10.1016/j.jviromet.2008.01.031. Epub 2008 Mar 24.


Expression of the human cytomegalovirus UL97 gene in a chimeric guinea pig cytomegalovirus (GPCMV) results in viable virus with increased susceptibility to ganciclovir and maribavir.

McGregor A, Choi KY, Cui X, McVoy MA, Schleiss MR.

Antiviral Res. 2008 Jun;78(3):250-9. doi: 10.1016/j.antiviral.2008.01.008. Epub 2008 Feb 14.


The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.

Schleiss MR, Bernstein DI, McVoy MA, Stroup G, Bravo F, Creasy B, McGregor A, Henninger K, Hallenberger S.

Antiviral Res. 2005 Jan;65(1):35-43.


Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy.

Schleiss MR, McVoy MA.

Expert Rev Anti Infect Ther. 2004 Jun;2(3):389-403. Review.


The structures of bovine herpesvirus 1 virion and concatemeric DNA: implications for cleavage and packaging of herpesvirus genomes.

Schynts F, McVoy MA, Meurens F, Detry B, Epstein AL, Thiry E.

Virology. 2003 Sep 15;314(1):326-35.


Down-regulation of surface major histocompatibility complex class I by guinea pig cytomegalovirus.

Lacayo J, Sato H, Kamiya H, McVoy MA.

J Gen Virol. 2003 Jan;84(Pt 1):75-81.


Tn7-mediated introduction of DNA sequences into bacmid-cloned cytomegalovirus genomes for rapid recombinant virus construction.

Hahn G, Jarosch M, Wang JB, Berbes C, McVoy MA.

J Virol Methods. 2003 Feb;107(2):185-94.


Supplemental Content

Loading ...
Support Center